Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News
Finnish Researchers Uncover Immune Mechanisms in an Autoimmune Disorder, Offering Hope for Potential Treatments
An international study led by researchers from the University of Helsinki highlights the role of natural killer cells in aplastic…
iCANDOC national get-together 2025
The event is an opportunity for all iCANDOC doctoral researchers and their supervisors to network and share their research and…
iCAN science seminar on Metabolic Challenges and Therapeutic Opportunities in Pancreatic Cancer with Assoc. Prof. Nada Kalaany
Welcome to the iCAN science seminar with Associate Professor Nada Kalaany (Harvard Medical School, Boston Children’s Hospital) on Metabolic Challenges…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding
